Cancer Clinical Trial -University of Southern California-0C-19-19/TGen 19-001

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

Drug

Pembrolizumab, Placebo for pembrolizumab, Cisplatin, External Beam Radiotherapy, Brachytherapy

Phase

Phase III

Condition

Solid Tumors

Keywords

Pancreatic Neoplasms, Immunological